CAMBRIDGE, Mass., March 21, 2018 /PRNewswire/ --áInfinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at BioCentury's25th Annual Future Leaders in the Biotech Industry Conference on Friday, March 23, 2018, at 8:30 a.m. ET at the Millennium Broadway Hotel and Conference Center in New
About InfinityInfinity is an innovative biopharmaceutical company dedicated to advancing novel medicines for people with cancer. Infinity is advancing IPI-549, an oral immuno-oncology development candidate that selectively inhibits PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Contact:Stephanie Ascher, Stern Investor Relations, Inc.212-362-1200 or Stephanie@sternir.com
View original content:http://www.prnewswire.com/news-releases/infinity-to-present-at-biocenturys-25th-annual-future-leaders-in-the-biotech-industry-conference-300617599.html
SOURCE Infinity Pharmaceuticals, Inc.
Subscribe to our Free Newsletters!
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...
Find out about travel shots or vaccination before you travel to your destination country. Travel ...
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...View All